Logo image of ISPR

ISPIRE TECHNOLOGY INC (ISPR) Stock Fundamental Analysis

NASDAQ:ISPR - Nasdaq - US46501C1009 - Common Stock - Currency: USD

2.93  -0.08 (-2.66%)

After market: 2.93 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ISPR. ISPR was compared to 8 industry peers in the Tobacco industry. ISPR may be in some trouble as it scores bad on both profitability and health. ISPR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ISPR had negative earnings in the past year.
ISPR had a negative operating cash flow in the past year.
ISPR Yearly Net Income VS EBIT VS OCF VS FCFISPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

With a Return On Assets value of -24.08%, ISPR is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
ISPR's Return On Equity of -188.51% is in line compared to the rest of the industry. ISPR outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -24.08%
ROE -188.51%
ROIC N/A
ROA(3y)-6.85%
ROA(5y)N/A
ROE(3y)-25.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ISPR Yearly ROA, ROE, ROICISPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

The Gross Margin of ISPR (21.24%) is worse than 62.50% of its industry peers.
In the last couple of years the Gross Margin of ISPR has grown nicely.
ISPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.08%
GM growth 5YN/A
ISPR Yearly Profit, Operating, Gross MarginsISPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

2

2. Health

2.1 Basic Checks

ISPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
ISPR has more shares outstanding than it did 1 year ago.
ISPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ISPR Yearly Shares OutstandingISPR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M 50M
ISPR Yearly Total Debt VS Total AssetsISPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ISPR has an Altman-Z score of 1.09. This is a bad value and indicates that ISPR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ISPR (1.09) is worse than 62.50% of its industry peers.
ISPR has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
ISPR has a better Debt to Equity ratio (0.08) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 1.09
ROIC/WACCN/A
WACC9.06%
ISPR Yearly LT Debt VS Equity VS FCFISPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

2.3 Liquidity

ISPR has a Current Ratio of 0.98. This is a bad value and indicates that ISPR is not financially healthy enough and could expect problems in meeting its short term obligations.
ISPR has a Current ratio of 0.98. This is in the better half of the industry: ISPR outperforms 62.50% of its industry peers.
ISPR has a Quick Ratio of 0.98. This is a bad value and indicates that ISPR is not financially healthy enough and could expect problems in meeting its short term obligations.
ISPR has a Quick ratio of 0.90. This is in the better half of the industry: ISPR outperforms 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.9
ISPR Yearly Current Assets VS Current LiabilitesISPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

ISPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -133.79%.
ISPR shows a decrease in Revenue. In the last year, the revenue decreased by -1.69%.
ISPR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.80% yearly.
EPS 1Y (TTM)-133.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-73.97%
Revenue 1Y (TTM)-1.69%
Revenue growth 3Y33.8%
Revenue growth 5YN/A
Sales Q2Q%-12.74%

3.2 Future

The Earnings Per Share is expected to grow by 17.89% on average over the next years. This is quite good.
ISPR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.38% yearly.
EPS Next Y-76.27%
EPS Next 2Y17.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.05%
Revenue Next 2Y16.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ISPR Yearly Revenue VS EstimatesISPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ISPR Yearly EPS VS EstimatesISPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ISPR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ISPR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ISPR Price Earnings VS Forward Price EarningsISPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ISPR Per share dataISPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

ISPR's earnings are expected to grow with 17.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.89%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ISPR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ISPIRE TECHNOLOGY INC

NASDAQ:ISPR (7/29/2025, 8:00:02 PM)

After market: 2.93 0 (0%)

2.93

-0.08 (-2.66%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryTobacco
Earnings (Last)05-09 2025-05-09/amc
Earnings (Next)09-24 2025-09-24/bmo
Inst Owners8.91%
Inst Owner Change0%
Ins Owners4.08%
Ins Owner Change2.7%
Market Cap167.45M
Analysts82.86
Price Target7.65 (161.09%)
Short Float %3.84%
Short Ratio10.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-75.65%
Min EPS beat(2)-96.08%
Max EPS beat(2)-55.23%
EPS beat(4)1
Avg EPS beat(4)-45.02%
Min EPS beat(4)-96.08%
Max EPS beat(4)34.64%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-6.58%
Min Revenue beat(2)-19.25%
Max Revenue beat(2)6.1%
Revenue beat(4)2
Avg Revenue beat(4)-7.9%
Min Revenue beat(4)-25.34%
Max Revenue beat(4)6.9%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.67%
EPS NQ rev (1m)-55.56%
EPS NQ rev (3m)-75%
EPS NY rev (1m)0%
EPS NY rev (3m)-18.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.96%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.16
P/FCF N/A
P/OCF N/A
P/B 11.33
P/tB 13.2
EV/EBITDA N/A
EPS(TTM)-0.49
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS2.53
BVpS0.26
TBVpS0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.08%
ROE -188.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.24%
FCFM N/A
ROA(3y)-6.85%
ROA(5y)N/A
ROE(3y)-25.95%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.08%
GM growth 5YN/A
F-Score3
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 59.28%
Cap/Sales 1.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.9
Altman-Z 1.09
F-Score3
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)1179.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-133.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-73.97%
EPS Next Y-76.27%
EPS Next 2Y17.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.69%
Revenue growth 3Y33.8%
Revenue growth 5YN/A
Sales Q2Q%-12.74%
Revenue Next Year0.05%
Revenue Next 2Y16.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-166.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-62.06%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-126.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-116.45%
OCF growth 3YN/A
OCF growth 5YN/A